Breakthrough vaccine for the deadliest skin cancer cut risk by almost half

A groundbreaking vaccine reduced the risk of death or recurrence of melanoma by almost half, an encouraging signal for a treatment seeking federal approval that has boosted the fortunes of drugmakers Moderna and Merck and could usher in a new wave of cancer treatments...

Read more from the Washington Post.